Metropolis Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/11/2026 ,inter alia, to consider and approve a) Un-audited standalone and consolidated financial results for the quarter and half year ended September 30, 2026; and b) Declaration of interim dividend, if any, on the equity shares of the Company for the financial year 2026-27.

Ref: MHL/Sec&Legal/2026-27/53 October 28, 2026 BSE Limited National Stock Exchange of India Limited Scrip Code: 542650 Scrip Symbol: METROPOLIS Dear Sir/Madam, Sub: Intimation of Board Meeting under Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 We wish to inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Tuesday, November 03, 2026, to inter alia: a) consider and approve unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2026; and b) consider declaration of interim dividend, if any, on the equity shares of the Company for the financial year 2026-27. In terms of the Company’s Code of Conduct for Prevention of Insider Trading, the Trading Window for dealing in the securities of the Company is closed from October 01, 2026, to November 05, 2026 (both days inclusive). You are requested to take the above information on record. Thanking you, Yours faithfully, For Metropolis Healthcare Limited Kamlesh C Kulkarni Head – Legal & Secretarial